Concepedia

Ying A. Wang

YA

Statistics

Publications

20

Citations

1.7K

H-Index

17

Active since

2006

Affiliations

University of Virginia(Current)

Brigham and Women's Hospital

Novartis (United States)

Harvard University

Novartis (Switzerland)

Ying A. Wang is an author at University of Virginia specializing in life sciences, medicine, and oncology.

Publications per year

2006–2023

20

Publications

20

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

Dominique Baeten, Xenofon Baraliakos, Jürgen Braun et al. · The Lancet · 2013 · 590 citations

Medicine, Clinical Sciences, Immunology +14

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer

Johan Vansteenkiste, Jean‐Luc Canon, Filippo de Braud et al. · Journal of Thoracic Oncology · 2015 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study

Marwan Fakih, Kanwal Pratap Singh Raghav, David Chang et al. · EClinicalMedicine · 2023 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17

The Structure of a Filamentous Bacteriophage

Ying A. Wang, Xiong Yu, Stacy A. Overman et al. · Journal of Molecular Biology · 2006 · 101 citations

Life Sciences, Biology, Microbiology +12

Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial

Connie Wong, Jason Baum, Angela Silvestro et al. · Cancer Research · 2020 · 100 citations · Full text

Medicine, Molecular Medicine, Oncology +17

1–5 of 20